Status:
NOT_YET_RECRUITING
Role of FDG PET/CT in Patients With Metastasis of Unknown Origin
Lead Sponsor:
Assiut University
Conditions:
Metastasis
Eligibility:
All Genders
18+ years
Brief Summary
Evaluatation of the role of F18FDG-PET/CT in patients with metastases of unknown origin.
Detailed Description
Cancer of unknown primary origin (CUP) includes a cluster of heterogeneous tumors that have exceptional clinical features: it is defined as early apparent metastatic disease with no recognizable prima...
Eligibility Criteria
Inclusion
- Patients with age more than 18 years presented with either pathologically proved metastases of unknown primary or
- Patients with clinico-radiological suspicious of having metastases.
Exclusion
- • Age below 18 years,
- patients with pathologically proved primary tumor,
- Patients suffering from advanced disease and in-cooperative patients.
- Pregnant and lactating women.
- Patients who had motion artifacts, or those who can't stay stable or calm during acquisition.
Key Trial Info
Start Date :
October 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
73 Patients enrolled
Trial Details
Trial ID
NCT06055764
Start Date
October 1 2023
End Date
December 1 2026
Last Update
September 28 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.